Scarica l'app Stockscreener
534.61
1.62%
-8.80
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ISRG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$543.41
Aprire:
$542.58
Volume 24 ore:
635.55K
Relative Volume:
0.32
Capitalizzazione di mercato:
$189.82B
Reddito:
$8.71B
Utile/perdita netta:
$2.48B
Rapporto P/E:
78.39
EPS:
6.82
Flusso di cassa netto:
$1.75B
1 W Prestazione:
+2.21%
1M Prestazione:
-3.21%
6M Prestazione:
+2.43%
1 anno Prestazione:
+22.55%
Intervallo 1D:
$531.67
$545.81
Intervallo di 1 settimana:
$521.26
$545.81
Portata 52W:
$413.82
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Nome
Intuitive Surgical Inc
Settore
Industria
Telefono
(408) 523-2100
Indirizzo
1020 KIFER ROAD, SUNNYVALE
Confronta ISRG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
534.47 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
176.18 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.69 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.20 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
220.37 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-09 | Downgrade | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Reiterato | Citigroup | Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-11-17 | Iniziato | HSBC Securities | Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-19 | Reiterato | BTIG Research | Buy |
| 2023-04-19 | Reiterato | BofA Securities | Buy |
| 2023-04-19 | Reiterato | Citigroup | Buy |
| 2023-04-19 | Reiterato | Evercore ISI | In-line |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-19 | Reiterato | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-19 | Reiterato | Raymond James | Outperform |
| 2023-04-19 | Reiterato | Stifel | Buy |
| 2023-04-19 | Reiterato | Truist | Buy |
| 2023-04-19 | Reiterato | Wells Fargo | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-23 | Iniziato | William Blair | Outperform |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Neutral |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Downgrade | Redburn | Buy → Neutral |
| 2022-01-21 | Reiterato | BTIG Research | Buy |
| 2022-01-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-21 | Reiterato | Deutsche Bank | Hold |
| 2022-01-21 | Reiterato | Evercore ISI | In-line |
| 2022-01-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Reiterato | Piper Sandler | Neutral |
| 2022-01-21 | Reiterato | Raymond James | Outperform |
| 2022-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2022-01-21 | Reiterato | Stifel | Buy |
| 2022-01-21 | Reiterato | UBS | Neutral |
| 2022-01-21 | Reiterato | Wells Fargo | Overweight |
| 2022-01-10 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2021-07-21 | Reiterato | BofA Securities | Neutral |
| 2021-07-21 | Reiterato | Citigroup | Buy |
| 2021-07-21 | Reiterato | JP Morgan | Overweight |
| 2021-07-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Reiterato | Piper Sandler | Neutral |
| 2021-07-21 | Reiterato | SVB Leerink | Mkt Perform |
| 2021-07-21 | Reiterato | Stifel | Buy |
| 2021-07-21 | Reiterato | UBS | Neutral |
| 2021-07-21 | Reiterato | Wells Fargo | Overweight |
| 2021-07-14 | Reiterato | Goldman | Buy |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Iniziato | Citigroup | Buy |
| 2020-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Iniziato | Argus | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-07-20 | Reiterato | Bernstein | Outperform |
| 2020-04-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Downgrade | CFRA | Hold → Sell |
| 2020-04-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Downgrade | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Reiterato | Wells Fargo | Outperform |
| 2019-11-21 | Iniziato | Oppenheimer | Perform |
| 2019-07-19 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-22 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-02 | Iniziato | Deutsche Bank | Buy |
| 2018-10-31 | Reiterato | Piper Jaffray | Overweight |
| 2018-10-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
Mostra tutto
Intuitive Surgical Inc Borsa (ISRG) Ultime notizie
ISRG vs BSX: Which Medical Device Stock Has More Room to Run? - The Globe and Mail
Virtual Incision Names Intuitive Veteran Jim Alecxih as CEO - Medical Product Outsourcing
Virtual Incision Appoints Jim Alecxih as Chief Executive Officer - Morningstar
Neurosurgery Surgical Robots Market Set to Witness Significant - openPR.com
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights - MSN
SS Innovations’ robot used in its first cardiac surgery in Americas - MedTech Dive
ISRG's Minimally Invasive Ecosystem Powers Surgical Precision - The Globe and Mail
The Top 5 Analyst Questions From Intuitive Surgical’s Q1 Earnings Call - Yahoo Finance
Intuitive Surgical (ISRG): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent
Unpleasant Surprises Could Be In Store For Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Shares - simplywall.st
Intuitive Surgical (ISRG) Earns 'Buy' Rating as Analyst Cites 'Ecosystem' Strength, Downplays Growth Threats - Daily Chhattisgarh News
William Blair Remains Bullish on Intuitive Surgical (ISRG) - MSN
Jim Cramer Notes “Intuitive Had Such a Great Quarter” - Insider Monkey
Healthcare Sector Taps AI Boom via Intuitive Surgical Stock (ISRG) - Yahoo Finance
Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 20 Years - Benzinga
Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst - Benzinga
Intuitive Surgical Ticks Higher, but Short-Term Downtrend Lingers Amid Strong Annual Gains - Daily Chhattisgarh News
BofA: Surgical robot remanufacturing not a major setback for Intuitive - MassDevice
Intuitive Surgical: The Market Might Exaggerate The Impact Of Remanufacturing (ISRG) - Seeking Alpha
AI-based Surgical Robots Market Generated Opportunities, - openPR.com
Intuitive Surgical Stock Is Falling. The MedTech Got Its First Sell Rating. - MSN
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds - Investing.com Nigeria
Virtua hospitals finalizing upgrade to latest robotic-assisted surgery technology - The Business Journals
Intuitive Surgical (ISRG) Share Price Continues Slide, Down Over 8% in a Month - Daily Chhattisgarh News
Micro Surgical Robot Market Set to Witness Significant Growth - openPR.com
Institutional investors in Intuitive Surgical, Inc. (NASDAQ:ISRG) lost 6.4% last week but have reaped the benefits of longer-term growth - Yahoo Finance
Intuitive Surgical Stock Falls. The MedTech Company Gets Its First Sell Rating. - MSN
Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors - AllSides
Intuitive Surgical (ISRG) Stock Dips, Bucking Strong Long-Term Growth Trend - Daily Chhattisgarh News
Intuitive Surgical Stock: Why This Correction Is Healthy And What Lies Ahead - Benzinga
ISRG Margin Outlook Dips on Tariffs, Demand Signals Stay Strong - Yahoo Finance
Intuitive Surgical analyst raises eyebrows with new stock price target - MSN
Intuitive Surgical Projects $165M Tariff Hit In 2025, Says Wait-And-See On Mitigation - insights.citeline.com
Capstan Medical's R&D head discusses the heart valve and robotics startup's tech, engineering challenges and solutions, advice for others in medtech and how to join his team - Medical Design & Outsourcing
Intuitive Surgical (ISRG) Ticks Up, But Faces Recent Headwinds Despite Strong Annual Gains - Daily Chhattisgarh News
Should You Invest in Intuitive Surgical (ISRG) Based on Bullish Wall Street Views? - MSN
Tesla, Intuitive Surgical downgraded: Wall Street’s top analyst calls - Yahoo Finance
Deutsche Bank Sounds Alarm on Intuitive Surgical Stock (ISRG) with a Rare ‘Sell’ Rating - TipRanks
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now? - Yahoo Finance
Intuitive Surgical (ISRG) Faces Instrument Reprocessing Risks | ISRG Stock News - GuruFocus
AI-driven Surgical Planning Tools Market Is Booming Worldwide | Intuitive Surgical, Brainlab, Stryker, Zimmer Biomet - openPR.com
Intuitive Surgical (NASDAQ:ISRG) Lowered to Sell Rating by Deutsche Bank Aktiengesellschaft - Defense World
Intuitive Surgical Inc (ISRG) Stock Price Down 6.75% on Jun 9 - GuruFocus
Why Intuitive Surgical Stock Plunged Today - MSN
Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Intuitive Surgical Inc Azioni (ISRG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rosa David J. | President |
Jun 10 '25 |
Option Exercise |
0.00 |
1,358 |
0 |
232,430 |
| Brosius Mark | SVP & Chief Mfg and Supply Cha |
Jun 06 '25 |
Sale |
563.11 |
216 |
121,632 |
907 |
| Brosius Mark | SVP & Chief Mfg and Supply Cha |
Jun 05 '25 |
Sale |
560.70 |
215 |
120,551 |
1,123 |
2.62%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):